Excitement of Clinical Investigation New Basic Mechanisms of Action After Drug Introduction

作者: Edward D. Frohlich

DOI: 10.1161/HYPERTENSIONAHA.108.116558

关键词:

摘要: Enormous personal satisfaction is frequently derived from experiences resulting systematic clinical investigation. Such are the lessons that have been learned tremendous insight has evolved concerning careful and fundamental study of new therapeutic agents, events after their release for general use. This case exciting gains into cardiac vascular remodeling introduction angiotensin-converting enzyme inhibitors statins. According to editors, an editorial commentary intended “highlight, provide a further perspective, enhance overall significance novel, timely, contributes our understanding physiology, pathophysiology, treatment or prevention hypertension.” To my way thinking, there no better example such article fulfill these criteria than “Modulation Angiotensin II–Mediated Hypertension Cardiac Remodeling by Lectin-Like, Oxidized Low-Density Lipoprotein Receptor-1 Deletion” Hu et al.1 Inherent in this its key words: angiotensin II, remodeling, lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1) deletion. Moreover, central thesis concept mechanisms cardiovascular “remodeling.” The role …

参考文章(12)
Muhammad T. Gill, Jaiwei Chen, J. L. Mehta, Dyslipidemia and Angiotensin II and Atherogenesis Springer US. pp. 143- 162 ,(2006) , 10.1007/0-387-27826-5_12
Marc A. Pfeffer, Edward D. Frohlich, Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 291, ,(2006) , 10.1152/AJPHEART.00647.2006
Jiawei Chen, Yong Liu, Hongmei Liu, Paul L. Hermonat, Jawahar L. Mehta, Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 26, pp. 1163- 1168 ,(2006) , 10.1161/01.ATV.0000209998.73303.B5
Janice M. Pfeffer, Marc A. Pfeffer, Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure The American Journal of Medicine. ,vol. 84, pp. 37- 44 ,(1988) , 10.1016/0002-9343(88)90203-3
Kui Chen, Jawahar L. Mehta, Dayuan Li, Lija Joseph, Jacob Joseph, Transforming Growth Factor β Receptor Endoglin Is Expressed in Cardiac Fibroblasts and Modulates Profibrogenic Actions of Angiotensin II Circulation Research. ,vol. 95, pp. 1167- 1173 ,(2004) , 10.1161/01.RES.0000150369.68826.2F
Kui Chen, Jiawei Chen, Yong Liu, Jin Xie, Dayuan Li, Tatsuya Sawamura, Paul L Hermonat, Jawahar L Mehta, None, Adhesion Molecule Expression in Fibroblasts: Alteration in Fibroblast Biology After Transfection With LOX-1 Plasmids Hypertension. ,vol. 46, pp. 622- 627 ,(2005) , 10.1161/01.HYP.0000179045.95915.B0
Changping Hu, Abhijit Dandapat, Liuqin Sun, Muhammad R. Marwali, Nobutaka Inoue, Fumiaki Sugawara, Kazuhiko Inoue, Yosuke Kawase, Kou-ichi Jishage, Hiroshi Suzuki, Paul L. Hermonat, Tatsuya Sawamura, Jawahar L. Mehta, Modulation of Angiotensin II–Mediated Hypertension and Cardiac Remodeling by Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Deletion Hypertension. ,vol. 52, pp. 556- 562 ,(2008) , 10.1161/HYPERTENSIONAHA.108.115287